Adhesive power and skin-related adverse event of two types of daily fentanyl transdermal patches

Adhesive power and skin-related adverse event of two types of daily fentanyl transdermal patches - Adhesive power and skin-related adverse event of two types of daily fentanyl transdermal patches

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005951

Enrollment

100

Registered

2011-07-08

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy

Interventions

Put two types of fentanyl transdermal patch preparation examples

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Malignancy 2) Need to be hospitalized at least 5 days 3) Without dementia 4) Aged 20 years old or above 5) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Severe skin disorder or wound on the upper arm or chest or abdomen or thigh 2) Having been registered before

Design outcomes

Primary

Measure	Time frame
Degree of detachment of fentanyl transdermal patch preparation examples	—

Countries

Japan

Contacts

Public ContactKosuke Takahashi

Aichi Cancer Center Aichi Hospital Department of Respiratory Medicine

ktakahashi@acc-aichi.com0564-21-6251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026